Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

HRS-5346

Phase 2Small molecule

SShandong Suncadia Medicine Co., Ltd.

1

Indications

4

Total Trials

2

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Lipoprotein DisorderNot yet recruiting

Lipoprotein DisorderPhase 2

Not yet recruiting

Timeline

Expected Milestones

Q4 2026

Phase 1Not yet recruiting

Lipoprotein Disorder

NCT07752069

Q2 2027

Phase 2Not yet recruiting

Lipoprotein Disorder

NCT07767513

Clinical

Trials by Indication[1]

Lipoprotein Disorder2 trials

A Randomized, Double-Blind Phase II Study to Evaluate the Efficacy and Safety of Oral HRS-5346 in Adult Patients With Elevated Lipoprotein(a) and High Risk of Cardiovascular Events

Not yet recruiting·SShandong Suncadia Medicine Co., Ltd.·Phase 2·NCT07767513·60 enrolled

Phase I Clinical Study Evaluating the Relative Bioavailability of Different Formulations of HRS-5346 in Healthy Participants

Not yet recruiting·SShandong Suncadia Medicine Co., Ltd.·Phase 1·NCT07752069·50 enrolled

Tolerance1 trial

Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy Subjects

Completed·SShandong Suncadia Medicine Co., Ltd.·Phase 1·NCT06441227·71 enrolled

Cardiovascular Events1 trial

A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Completed·SShandong Suncadia Medicine Co., Ltd.·Phase 2·NCT06816264·120 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for HRS-5346. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — HRS-5346 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for HRS-5346. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Shandong Suncadia Medicine Co., Ltd. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: SShandong Suncadia Medicine Co., Ltd.

Related News